Dimethylarsinic acid: Results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice

Toxicology

Volumn 223, Issue 1-2, 2006, Pages 82-100

  Arnold, Lora L ^a   Eldan, Michal ^b   Nyska, Abraham ^c   van Gemert, Marcia ^d   Cohen, Samuel M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Luxembourg Industries Pamol Ltd   (Israel)

^c Life Science Research Israel   (Israel)

^d EXPONENT INC   (United States)

Author keywords

Bladder carcinogenesis; Dimethylarsinic acid; Methylated arsenical; Organic arsenic compound

Indexed keywords

CACODYLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CELL DEGENERATION; CELL HYPERPLASIA; CHRONIC TOXICITY; CONTROLLED STUDY; FEMALE; GLOMERULOPATHY; KIDNEY CALCIFICATION; MALE; MORTALITY; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PYELONEPHRITIS; RAT;

ADMINISTRATION, ORAL; ANIMALS; CACODYLIC ACID; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HERBICIDES; MALE; MICE; MICE, INBRED STRAINS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RATS; RATS, INBRED F344; SEX FACTORS; SPECIES SPECIFICITY; TOXICITY TESTS, CHRONIC; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 33646581734     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.03.013     Document Type: Article

References (49)

1. Aposhian H.V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 397-419
2. Arnold L.L., Cano M., St. John M., Eldan M., van Gemert M., and Cohen S.M. Effects of dietary dimethylarsinic acid on the urine and urothelium of rats. Carcinogenesis 20 (1999) 2171-2179
3. III). Toxicologist 72 (2003) 232
4. Bernstam L., and Nriagu J. Molecular aspects of arsenic stress. J. Toxicol. Environ. Health B-Crit. Rev. 3 (2000) 293-322
5. Brown J.L., Kitchin K.T., and George M. Dimethylarsinic acid treatment alters six different rat biochemical parameters: relevance to arsenic carcinogenesis. Teratogen. Carcinogen. Mutagen. 17 (1997) 71-84
6. Buchet J.P., Lauwerys R., and Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 48 (1981) 71-79
7. Cohen S.M. Toxic and non-toxic changes induced in the urothelium by xenobiotics. Toxicol. Appl. Pharmacol. 101 (1989) 484-498
8. Cohen S.M., Yamamoto S., Cano M., and Arnold L.L. Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats. Toxicol. Sci. 59 (2001) 68-74
9. Cohen S.M., Arnold L.L., Uzvolgyi E., St. John M., Yamamoto S., Lu X., and Lee W. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 15 (2002) 1150-1157
10. Cohen S.M., Wanibuchi H., and Fukushima S. Lower urinary tract. In: Haschek W.M., Rousseaux C.G., and Wallig M.A. (Eds). Handbook of Toxicologic Pathology. 2nd ed. Vol. 2 (2002), Academic Press, San Diego 337-361
11. Eguchi N., Kuroda K., and Endo G. Metabolites of arsenic induced tetraploids and mitotic arrest in cultured cells. Arch. Environ. Contam. Toxicol. 32 (1997) 141-145
12. Endo G., Kuroda K., Okamoto A., and Horiguchi S. Dimethylarsenic acid induces tetraploids in Chinese hamster cells. Bull. Environ. Contam. Toxicol. 48 (1992) 131-137
13. Experimental Pathology Laboratories Inc., 2000. Pathology Working Group (PWG) Peer Review of Subcutaneous Neoplasms from a Dimethylarsinic Acid Oncogenicity Study in Mouse (MRID No. 41914601). EPA Project No. 666-001. Research Triangle Park, NC.
14. Hayashi H., Kanisawa M., Yamanaka K., Ito T., Udaka N., Ohji H., Okudela K., Okada S., and Kitamura H. Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice. Cancer Lett. 13 (1998) 83-88
15. Hill R.N., Erdreich L.S., Paynter O.E., Roberts P.A., Rosenthal S.L., and Wilkinson C.F. Thyroid follicular cell carcinogenesis. Fund. Appl. Toxicol. 12 (1989) 629-697
16. Hughes M.F., and Kenyon E.M. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. J. Toxicol. Environ. Health A 53 (1998) 95-112
17. Kato K., Hayashi H., Hasegawa A., Yamanaka K., and Okada S. DNA damage induced in cultured human alveolar (L-132) cells by exposure to dimethylarsinic acid. Environ. Health Perspect. 102 Suppl. 3 (1994) 285-288
18. Kenyon E.M., and Hughes M.F. A concise review of the toxicity and carcinogenicity of dimethylarsinic acid. Toxicology 160 (2001) 227-236
19. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172 (2001) 249-261
20. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., and Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72 (2000) 5172-5177
21. Lewandowski T.A., Seeley M.R., and Beck B.D. Interspecies differences in susceptibility to perturbation of thyroid homeostasis: a case study with perchlorate. Regul. Toxicol. Pharmacol. 39 (2004) 348-362
22. Lu M., Wang H., Li X.-F., Lu X., Cullen W.R., Arnold L.L., Cohen S.M., and Le X.C. Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Chem. Res. Toxicol. 17 (2004) 1733-1742
23. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J. Am. Stat. Assoc. 58 (1963) 690-700
24. McConnell E.E., Solleveld H.A., Swenberg J.A., and Boorman G.A. Guidelines for combining neoplasms for evaluation in rodents. J. Natl. Cancer Inst. 76 (1986) 283-289
25. Marafante E., Vahter M., Norin H., Envall J., Sandström, and Christakopoulos A. Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 7 (1987) 111-117
26. Morikawa T., Wanibuchi H., Morimura K., Ogawa M., and Fukushima S. Promotion of skin carcinogenesis by dimethylarsinic acid in Keratin (K6)/ODC transgenic mice. Jpn. J. Cancer Res. 91 (2000) 579-581
27. National Research Council (NRC) Subcommittee on Arsenic in Drinking Water, 1999. In: Arsenic in Drinking Water, National Academy Press, Washington, DC.
28. National Research Council (NRC) Committee to Assess the Health Implications of Perchlorate Ingestion, 2005. Health Implications of Perchlorate Ingestion. National Academy Press, Washington, DC.
29. Oya-Ohta Y., Kaise T., and Ochi T. Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. Mutat. Res. 357 (1996) 123-129
30. Peto, R., Pike, M., Day, N., Gray, R., Lee, P., Parish, S., Peto, J., Richards, S., Wahrendorf, J., 1980. Guidelines for simple, sensitive, significant tests for carcinogenic effects in long-term animal experiments. In: Long-term and Short-term Screening Assays for Carcinogens: A Critical Appraisal. IARC Monograph, Suppl. 2. World Health Organization, Geneva, pp. 311-426.
31. Rossman T.G. Molecular and genetic toxicology of arsenic. In: Rose J. (Ed). Environmental Toxicology: Current Developments (1998), Gordon and Breach Publishers, Amsterdam pp. 171-187
32. Salim E.I., Wanibuchi H., Morimura K., Wei M., Mitsuhashi M., Yoshida K., Endo G., and Fukushima S. Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice. Carcinogenesis 24 (2003) 335-342
33. Seike N., Wanibuchi H., Morimura K., Nishikawa T., Kishida H., Nakae D., Hirata K., and Fukushima S. Lack of promoting effect due to oral administration of dimethylarsinic acid on rat lung carcinogenesis initiated with N-bis(2-hydroxypropyl)nitrosamine. Cancer Lett. 175 (2002) 113-119
34. III) by red blood cells. Chem. Res. Toxicol. 14 (2001) 1446-1452
35. U.S. Environmental Protection Agency (USEPA), 1998. Assessment of thyroid follicular cell tumors. Risk Assessment Forum, EPA/630/R-97/002.
36. U.S. Environmental Protection Agency (USEPA), 2003. Dimethylarsinic Acid (012501): response to comments concerning mouse carcinogenicity study, special mode of action, and proposed mode of action. Office of Prevention, Pesticides and Toxic Substances, Washington, DC (Memorandum from R.F. Fricke to D. Helder (through A. Nielsen)).
37. van Gemert, M., Eldan, M., 1998. Chronic carcinogenicity assessment of cacodylic acid. In: Society for Environmental Geochemistry and Health (SEGH) Third International Conference on Arsenic Exposure and Health Effects, Book of Abstracts. San Diego, CA, 12-15 July, p. 113.
38. Wang Z., and Rossman T.G. The carcinogenicity of arsenic. In: Chang L.W. (Ed). Toxicology of Metals (1996), CRC Lewis Publishers, Boca Raton, FL pp. 221-229
39. Wang Z., Zhou J., Lu X., Gong Z., and Le X.C. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Chem. Res. Toxicol. 17 (2004) 95-103
40. Wanibuchi H., Yamamoto S., Chen H., Yoshida K., Endo G., Hori T., and Fukushima S. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Carcinogenesis 17 (1996) 2435-2439
41. Wei M., Wanibuchi H., Yamamoto S., Li W., and Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcninogenesis 20 (1999) 1873-1876
42. Wei M., Wanibuchi H., Morimura K., Iwai S., Yoshida K., Endo G., Nakae D., and Fukushima S. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 23 (2002) 1387-1397
43. Yamamoto S., Konishi Y., Matsuda T., Murai T., Shibata M.A., Matsui-Yuasa I., Otani S., Kuroda K., Endo G., and Fukushima S. Cancer induced by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55 (1995) 1271-1276
44. Yamanaka K., Hasegawa A., Sawamura R., and Okada S. DNA strand breaks in mammalian tissues induced by methylarsenics. Biol. Trace Elem. Res. 21 (1989) 413-417
45. Yamanaka K., Hoshino M., Okamoto M., Sawamura R., Hasegawa A., and Okada S. Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. Biochem. Biophys. Res. Commun. 168 (1990) 58-64
46. Yamanaka K., Tezuka M., Kato K., Hasegawa A., and Okada S. Crosslink formation between DNA and nuclear proteins by in vivo and in vitro exposure of cells to dimethylarsinic acid. Biochem. Biophys. Res. Commun. 191 (1993) 1184-1191
47. Yamanaka K., Ohtsubo K., Hasegawa A., Hayashi H., Ohji H., Kanisawa M., and Okada S. Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice. Carcinogenesis 17 (1996) 767-770
48. Yamanaka K., Katsumata K., Ikuma K., Hasegawa A., Nakano M., and Okada S. The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice. Cancer Lett. 152 (2000) 79-85
49. Yoshida K., Inoue Y., Kuroda K., Chen H., Wanibuchi H., Fukushima S., and Endo G. Urinary excretion of arsenic metabolites after long-term oral administration of various arsenic compounds to rats. J. Toxicol. Environ. Health A 54 (1998) 179-192